Fred van Leuven
Corporate Officer/Principal chez Katholieke Universiteit Leuven
Postes actifs de Fred van Leuven
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| Katholieke Universiteit Leuven | Corporate Officer/Principal | - | - |
Historique de carrière de Fred van Leuven
Anciens postes connus de Fred van Leuven
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| AC IMMUNE SA | Fondateur | 13/02/2003 | - |
reMYND NV
 reMYND NV Miscellaneous Commercial ServicesCommercial Services reMYND NV engages in the development of disease-modifying treatments against alzheimer's, parkinson's, diabetes and other protein misfolding disorders. Its drug and development unit focuses on innovative, disease-modifying drugs for treating degenerative disorders. The company was founded by Fred Van Leuven, Stefaan Wera and Joris Winderickx in 2002 and is headquartered in Leuven, Belgium. | Fondateur | 01/01/2002 | - |
Formation de Fred van Leuven
| Ghent University | Graduate Degree |
Statistiques
Internationale
| Belgique | 4 |
| Suisse | 2 |
Opérationnelle
| Founder | 2 |
| Graduate Degree | 1 |
| Corporate Officer/Principal | 1 |
Sectorielle
| Consumer Services | 3 |
| Commercial Services | 2 |
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| AC IMMUNE SA | Health Technology |
| Entreprise privées | 1 |
|---|---|
reMYND NV
reMYND NV Miscellaneous Commercial ServicesCommercial Services reMYND NV engages in the development of disease-modifying treatments against alzheimer's, parkinson's, diabetes and other protein misfolding disorders. Its drug and development unit focuses on innovative, disease-modifying drugs for treating degenerative disorders. The company was founded by Fred Van Leuven, Stefaan Wera and Joris Winderickx in 2002 and is headquartered in Leuven, Belgium. | Commercial Services |
- Bourse
- Insiders
- Fred van Leuven
- Expérience
